An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy
Clinical trial NCT02065856 · COMPLETED
Trial details
- NCT number
- NCT02065856
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-08-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.